Xin Lang Cai Jing·2025-11-21 11:36Group 1 - The core viewpoint of the news highlights the recent performance and financial metrics of Spring Medical, including stock price movement and financing activities [1] - On November 20, Spring Medical's stock fell by 1.01%, with a trading volume of 27.14 million yuan, and a net financing outflow of 393,400 yuan [1] - As of November 20, the total margin balance for Spring Medical was 51.40 million yuan, accounting for 0.70% of its market capitalization, indicating a high level of financing activity compared to the past year [1] Group 2 - Spring Medical, established on February 12, 1998, specializes in the research, production, and sales of implantable orthopedic medical devices, with a primary focus on joint prosthetics and spinal implants [2] - The company reported a revenue of 756 million yuan for the first nine months of 2025, representing a year-on-year growth of 48.75%, and a net profit of 192 million yuan, which is a 213.21% increase compared to the previous year [2] - The company has distributed a total of 359 million yuan in dividends since its A-share listing, with 309 million yuan distributed over the last three years [3] Group 3 - As of September 30, 2025, the number of shareholders for Spring Medical increased by 4.12% to 6,164, while the average circulating shares per person decreased by 3.95% to 46,906 shares [2] - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited is the fourth largest with 2.96 million shares, while two new shareholders, China Europe Economic Growth Mixed A and Ping An Low Carbon Economy Mixed A, are also noted [3]